[144] Ovintiv Inc. SEC Filing

Ovintiv Inc. insider stock sale notice: Gregory Dean Givens plans to sell 50,000 shares of Ovintiv common stock through J.P.

Rhea-AI Filing Summary

Ovintiv Inc. insider stock sale notice: Gregory Dean Givens plans to sell 50,000 shares of Ovintiv common stock through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $2,026,500 and 253,258,560 common shares reported as outstanding. The shares were originally acquired from the issuer as compensation in three annual grants on 03/08/2020, 03/08/2021, and 03/08/2022 totaling 50,000 shares. In the past three months, Givens also sold 50,000 common shares on 12/04/2025 for gross proceeds of $2,125,000.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/11/2025 - 04:01 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001788619
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OVINTIV INC
SEC File Number	001-39191
Address of Issuer	SUITE 1700 370 - 17 STREET Denver COLORADO 80202
Phone	3036232300
Name of Person for Whose Account the Securities are To Be Sold	Gregory Dean Givens
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	COO

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 270 Park Avenue 10th Floor New York NY 10017	50000	2026500	253258560	12/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/08/2020	Compensation	Issuer			16667	03/08/2020	NA
Common	03/08/2021	Compensation	Issuer			16667	03/08/2021	NA
Common	03/08/2022	Compensation	Issuer			16666	03/08/2022	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
GREGORY DEAN GIVENS SUITE 1700 370 - 17 STREET Denver CO 80202	Common	12/04/2025	50000	2125000

144: Remarks and Signature

Remarks
Date of Notice	12/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Gregory Dean Givens
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)